-
1
-
-
1642493618
-
Long-term persistence of anti-HBs after vaccination against HBV: An 18 year experience in health care workers
-
Floreani A, et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine 2004;22:608-611.
-
(2004)
Vaccine
, vol.22
, pp. 608-611
-
-
Floreani, A.1
-
2
-
-
0001566476
-
Are booster immunisations needed for lifelong hepatitis B immunity?
-
European Consensus Group on Hepatitis B Immunity
-
European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000;12:561-565.
-
(2000)
Lancet
, vol.12
, pp. 561-565
-
-
-
3
-
-
20444483260
-
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
-
FitzSimons D, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005;23:4158-4166.
-
(2005)
Vaccine
, vol.23
, pp. 4158-4166
-
-
FitzSimons, D.1
-
4
-
-
33947604533
-
Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents
-
Gabbuti A, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 2007;25:3129-3132.
-
(2007)
Vaccine
, vol.25
, pp. 3129-3132
-
-
Gabbuti, A.1
-
5
-
-
34548567080
-
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years
-
Hammitt LL, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years. Vaccine 2007;25:6958-6964.
-
(2007)
Vaccine
, vol.25
, pp. 6958-6964
-
-
Hammitt, L.L.1
-
6
-
-
0037219807
-
Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan
-
Lin YC, et al. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. Journal of Infectious Diseases 2003;187:134-138.
-
(2003)
Journal of Infectious Diseases
, vol.187
, pp. 134-138
-
-
Lin, Y.C.1
-
7
-
-
0035971964
-
Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine
-
Watson B, et al. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine 2001;19:3164-3168.
-
(2001)
Vaccine
, vol.19
, pp. 3164-3168
-
-
Watson, B.1
-
8
-
-
26644435772
-
Long-term immunogenicity of hepatitis B vaccination and policy for booster: An Italian multicentre study
-
Zanetti A, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005;366:1379-1384.
-
(2005)
Lancet
, vol.366
, pp. 1379-1384
-
-
Zanetti, A.1
-
9
-
-
0024465239
-
Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination
-
Shaw FE, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-430.
-
(1989)
Vaccine
, vol.7
, pp. 425-430
-
-
Shaw, F.E.1
-
10
-
-
0026515799
-
Low-dose intradermal and intramuscular vaccination against hepatitis B
-
Bryan JP, et al. Low-dose intradermal and intramuscular vaccination against hepatitis B. Clinical Infectious Diseases 1992;14:697-707.
-
(1992)
Clinical Infectious Diseases
, vol.14
, pp. 697-707
-
-
Bryan, J.P.1
-
11
-
-
84944370149
-
Obesity as a predictor of poor antibody response to hepatitis B plasma
-
Weber DJ, et al. Obesity as a predictor of poor antibody response to hepatitis B plasma. Journal of the American Medical Association 1985;254:3187-3189.
-
(1985)
Journal of the American Medical Association
, vol.254
, pp. 3187-3189
-
-
Weber, D.J.1
-
12
-
-
0029846451
-
Nonresponse to hepatitis B vaccines and the kinetics of Anti-HBs production
-
Zuckerman JN. Nonresponse to hepatitis B vaccines and the kinetics of Anti-HBs production. Journal of Medical Virology 1996;50:283-288.
-
(1996)
Journal of Medical Virology
, vol.50
, pp. 283-288
-
-
Zuckerman, J.N.1
-
13
-
-
24944459721
-
Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth
-
Dentinger C, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatric Infectious Disease Journal 2005;24:786-792.
-
(2005)
Pediatric Infectious Disease Journal
, vol.24
, pp. 786-792
-
-
Dentinger, C.1
-
14
-
-
0036841372
-
Immunogenicity of hepatitis B vaccines: Implications of immune memory
-
Koff RS. Immunogenicity of hepatitis B vaccines: implications of immune memory. Vaccine 2002;20:3695-3701.
-
(2002)
Vaccine
, vol.20
, pp. 3695-3701
-
-
Koff, R.S.1
-
15
-
-
1042304316
-
Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination
-
Wang R, et al. Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination. World Journal of Gastroenterology 2004;10:260-263.
-
(2004)
World Journal of Gastroenterology
, vol.10
, pp. 260-263
-
-
Wang, R.1
-
16
-
-
29544432932
-
Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
-
Bauer T, Jilg W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006;24:572-577.
-
(2006)
Vaccine
, vol.24
, pp. 572-577
-
-
Bauer, T.1
Jilg, W.2
-
18
-
-
38349041323
-
Recommendations of the German Standing Vaccination Committee (STIKO) at the Robert Koch Institute (as of July 2007) [in German]
-
Standige Impfkommission am Robert Koch-Institut
-
Standige Impfkommission am Robert Koch-Institut. Recommendations of the German Standing Vaccination Committee (STIKO) at the Robert Koch Institute (as of July 2007) [in German]. Epidemiologisches Bulletin 2007;30:267-286.
-
(2007)
Epidemiologisches Bulletin
, vol.30
, pp. 267-286
-
-
-
19
-
-
34250163248
-
Vaccination coverage and predictors for vaccination level. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)
-
Poethko-Müller C, Kuhnert R, Schlaud M. Vaccination coverage and predictors for vaccination level. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007;50:851-862.
-
(2007)
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
, vol.50
, pp. 851-862
-
-
Poethko-Müller, C.1
Kuhnert, R.2
Schlaud, M.3
-
20
-
-
29244439937
-
Immunisation status of children in Germany: Temporal trends and regional differences
-
Kalies H, et al. Immunisation status of children in Germany: temporal trends and regional differences. European Journal of Pediatrics 2006;165:30-36.
-
(2006)
European Journal of Pediatrics
, vol.165
, pp. 30-36
-
-
Kalies, H.1
-
21
-
-
77957291804
-
-
European Medicines Agency, London, United Kingdom, Accessed 26 June 2009
-
European Medicines Agency. Questions and answers on the suspension of Hexavac, 2005, London, United Kingdom (http://www.ema.europa.eu/humandocs/PDFs/ EPAR/Hexavac/30488805enpdf). Accessed 26 June 2009.
-
(2005)
Questions and Answers on the Suspension of Hexavac
-
-
-
23
-
-
63349092540
-
Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age
-
Kilpi T, et al. Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age. Human Vaccines 2009;5:18-25.
-
(2009)
Human Vaccines
, vol.5
, pp. 18-25
-
-
Kilpi, T.1
-
24
-
-
0034530921
-
Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants
-
Mallet E, et al. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Pediatric Infectious Disease Journal 2000;19:1119-1127.
-
(2000)
Pediatric Infectious Disease Journal
, vol.19
, pp. 1119-1127
-
-
Mallet, E.1
-
25
-
-
11144357611
-
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: Review of immunogenicity and safety
-
Mallet E, et al. A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety. Vaccine 2004;22:1343-1357.
-
(2004)
Vaccine
, vol.22
, pp. 1343-1357
-
-
Mallet, E.1
-
26
-
-
33845893335
-
Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccines and evaluation of booster vaccination
-
Tichmann I, et al. Persistence of antibodies in children primed with two different hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccines and evaluation of booster vaccination. Human Vaccines 2006;2:249-254.
-
(2006)
Human Vaccines
, vol.2
, pp. 249-254
-
-
Tichmann, I.1
-
27
-
-
20244380489
-
Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age
-
Tichmann I, et al. Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age. Vaccine 2005;23:3272-3279.
-
(2005)
Vaccine
, vol.23
, pp. 3272-3279
-
-
Tichmann, I.1
-
28
-
-
46149126153
-
The challenge of comprehensively mapping children's health in a nation-wide health survey: Design of the German KiGGS Study
-
Kurth B-M, et al. The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS Study. BMC Public Health 2008;8:196.
-
(2008)
BMC Public Health
, vol.8
, pp. 196
-
-
Kurth, B.-M.1
-
29
-
-
34250199753
-
The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): Study management and conduct of fieldwork [in German]
-
Hölling H, et al. The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): study management and conduct of fieldwork [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007;50:557-566.
-
(2007)
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
, vol.50
, pp. 557-566
-
-
Hölling, H.1
-
30
-
-
34250158133
-
Biochemical measures in the german health interview and examination survey for children and adolescents (KiGGS)
-
Thierfelder W, et al. Biochemical measures in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007;50:757-770.
-
(2007)
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
, vol.50
, pp. 757-770
-
-
Thierfelder, W.1
-
31
-
-
0023932027
-
Persistence of specific antibodies after hepatitis B vaccination
-
Jilg W, Schmidt M, Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. Journal of Hepatology 1988;6:201-207.
-
(1988)
Journal of Hepatology
, vol.6
, pp. 201-207
-
-
Jilg, W.1
Schmidt, M.2
Deinhardt, F.3
-
32
-
-
33646903917
-
Long-term protection against carriage of hepatitis B virus after infant vaccination
-
van der Sande MA, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. Journal of Infectious Diseases 2006;193:1528-1535.
-
(2006)
Journal of Infectious Diseases
, vol.193
, pp. 1528-1535
-
-
Van Der Sande, M.A.1
-
33
-
-
20044369702
-
Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up
-
McMahon BJ, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Annals of Internal Medicine 2005;142:333-341.
-
(2005)
Annals of Internal Medicine
, vol.142
, pp. 333-341
-
-
McMahon, B.J.1
-
34
-
-
0035815499
-
Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy
-
Faustini A, et al. Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine 2001;19:2812-2818.
-
(2001)
Vaccine
, vol.19
, pp. 2812-2818
-
-
Faustini, A.1
-
35
-
-
51249123074
-
A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines
-
Giambi C, et al. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. BMC Infectious Diseases 2008;8:100.
-
(2008)
BMC Infectious Diseases
, vol.8
, pp. 100
-
-
Giambi, C.1
-
36
-
-
33845592245
-
Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: Safety, immunogenicity and persistence of antibody responses
-
Heininger U, et al. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Vaccine 2007;25:1055-1063.
-
(2007)
Vaccine
, vol.25
, pp. 1055-1063
-
-
Heininger, U.1
-
37
-
-
0031906599
-
Immune responses of prematurely born infants to hepatitis B vaccination: Results through three years of age
-
Kesler K, et al. Immune responses of prematurely born infants to hepatitis B vaccination: results through three years of age. Paediatric Infectious Disease Journal 1998;17:116-119.
-
(1998)
Paediatric Infectious Disease Journal
, vol.17
, pp. 116-119
-
-
Kesler, K.1
-
38
-
-
0033072970
-
Hepatitis B vaccination of premature infants: A reassessment of current recommendations for delayed immunization
-
Losonsky GA, et al. Hepatitis B vaccination of premature infants: A reassessment of current recommendations for delayed immunization. Pediatrics 1999;103:e14.
-
(1999)
Pediatrics
, vol.103
-
-
Losonsky, G.A.1
-
39
-
-
0026497303
-
Response of preterm infants to hepatitis B vaccine
-
Lau YL, et al. Response of preterm infants to hepatitis B vaccine. Journal of Pediatrics 1992;121:962-965.
-
(1992)
Journal of Pediatrics
, vol.121
, pp. 962-965
-
-
Lau, Y.L.1
-
40
-
-
44749093483
-
Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants
-
Olivier C, et al. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants. Vaccine 2008;26:3142-3152.
-
(2008)
Vaccine
, vol.26
, pp. 3142-3152
-
-
Olivier, C.1
-
41
-
-
13944279225
-
Immunogenicity and reactogenicity of four doses of diphtheria-tetanus threecomponent acellular pertussis-hepatitis B-inactivated polio virus Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine
-
Tichmann-Schumann I, et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus threecomponent acellular pertussis-hepatitis B-inactivated polio virus Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine. Pediatric Infectious Disease Journal 2005;24:70-77.
-
(2005)
Pediatric Infectious Disease Journal
, vol.24
, pp. 70-77
-
-
Tichmann-Schumann, I.1
-
42
-
-
33947576357
-
Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals
-
Da Villa G, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007;25:3133-3136.
-
(2007)
Vaccine
, vol.25
, pp. 3133-3136
-
-
Villa, G.D.1
-
43
-
-
54049124753
-
Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: A 15-year follow-up study
-
Bialek SR, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatric Infectious Disease Journal 2008;27:881-885.
-
(2008)
Pediatric Infectious Disease Journal
, vol.27
, pp. 881-885
-
-
Bialek, S.R.1
-
44
-
-
0037077927
-
Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children
-
Whittle H, et al. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. British Medical Journal 2002;14:569-573.
-
(2002)
British Medical Journal
, vol.14
, pp. 569-573
-
-
Whittle, H.1
-
45
-
-
34547687759
-
Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy
-
Samandari T, et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 2007;120:e373-e381.
-
(2007)
Pediatrics
, vol.120
-
-
Samandari, T.1
-
46
-
-
24144500737
-
Hepatitis B and C risk factors in Germany - Results of the national surveillance [in German]
-
Walter J, et al. Hepatitis B and C risk factors in Germany - results of the national surveillance [in German]. Gesundheitswesen 2005;67:441-447.
-
(2005)
Gesundheitswesen
, vol.67
, pp. 441-447
-
-
Walter, J.1
-
47
-
-
77957313749
-
Notification to health experts, 20 September 2005: Swissmedic suspends the license of the Hexavac vaccine [in German]
-
Swissmedic. Notification to health experts, 20 September 2005: Swissmedic suspends the license of the Hexavac vaccine [in German]. Swissmedic Journal 2005;9:678-679.
-
(2005)
Swissmedic Journal
, vol.9
, pp. 678-679
-
-
Swissmedic1
-
48
-
-
0347163892
-
-
WHO, World Health Organization, Accessed 30 October 2009
-
WHO. International Classification of Diseases (ICD), 2007. World Health Organization (http://apps.who.int/classifications/apps/icd/icd10online/). Accessed 30 October 2009.
-
(2007)
International Classification of Diseases (ICD)
-
-
|